Mitsuhiro Kitagawa

573 total citations
11 papers, 377 citations indexed

About

Mitsuhiro Kitagawa is a scholar working on Molecular Biology, Pharmacology and Neurology. According to data from OpenAlex, Mitsuhiro Kitagawa has authored 11 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Neurology. Recurrent topics in Mitsuhiro Kitagawa's work include Endoplasmic Reticulum Stress and Disease (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Photosynthetic Processes and Mechanisms (2 papers). Mitsuhiro Kitagawa is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Photosynthetic Processes and Mechanisms (2 papers). Mitsuhiro Kitagawa collaborates with scholars based in Japan, United Kingdom and United States. Mitsuhiro Kitagawa's co-authors include Masaya Imoto, Etsu Tashiro, Yushi Futamura, Tomoyoshi Soga, Makoto Muroi, Hideo Okumura, Makoto Kawatani, Naoshi Dohmae, Masamichi Takami and Kaori Honda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and PLoS ONE.

In The Last Decade

Mitsuhiro Kitagawa

10 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuhiro Kitagawa Japan 7 245 84 54 48 39 11 377
Rohini Gomathinayagam United States 11 286 1.2× 48 0.6× 26 0.5× 55 1.1× 44 1.1× 17 459
Harumi Aono Japan 12 258 1.1× 83 1.0× 27 0.5× 44 0.9× 34 0.9× 25 392
Soumasree De India 9 231 0.9× 51 0.6× 46 0.9× 26 0.5× 62 1.6× 12 359
Jordan O’Malley United States 11 386 1.6× 129 1.5× 98 1.8× 24 0.5× 75 1.9× 12 580
Fatima Rizvi United States 9 290 1.2× 39 0.5× 50 0.9× 21 0.4× 62 1.6× 21 482
Sung Youl Kim South Korea 10 261 1.1× 106 1.3× 41 0.8× 17 0.4× 75 1.9× 12 429
Jessica Nowacki Germany 8 278 1.1× 110 1.3× 26 0.5× 26 0.5× 12 0.3× 9 424
Lixia Pu United States 9 400 1.6× 40 0.5× 62 1.1× 33 0.7× 26 0.7× 15 506
Jintong Yang China 14 253 1.0× 68 0.8× 16 0.3× 27 0.6× 37 0.9× 18 437

Countries citing papers authored by Mitsuhiro Kitagawa

Since Specialization
Citations

This map shows the geographic impact of Mitsuhiro Kitagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuhiro Kitagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuhiro Kitagawa more than expected).

Fields of papers citing papers by Mitsuhiro Kitagawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuhiro Kitagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuhiro Kitagawa. The network helps show where Mitsuhiro Kitagawa may publish in the future.

Co-authorship network of co-authors of Mitsuhiro Kitagawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuhiro Kitagawa. A scholar is included among the top collaborators of Mitsuhiro Kitagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuhiro Kitagawa. Mitsuhiro Kitagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sasazawa, Yukiko, Daisuke Noshiro, Mitsuhiro Kitagawa, et al.. (2025). Ubiquilin-2 liquid droplets catalyze α-synuclein fibril formation. The EMBO Journal. 44(22). 6527–6555.
2.
Sasazawa, Yukiko, Mitsuhiro Kitagawa, Hideyuki Saya, et al.. (2024). Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease. eLife. 13. 9 indexed citations
3.
Fujimaki, Takahiro, Shinji Saiki, Etsu Tashiro, et al.. (2014). Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease. PLoS ONE. 9(6). e100395–e100395. 29 indexed citations
4.
Ternette, Nicola, Ming Yang, Mitsuhiro Kitagawa, et al.. (2013). Inhibition of Mitochondrial Aconitase by Succination in Fumarate Hydratase Deficiency. Cell Reports. 3(3). 689–700. 124 indexed citations
5.
Takemoto, Yasushi, Masato Sawada, Mitsuhiro Kitagawa, et al.. (2013). Novel derivatives of aclacinomycin A block cancer cell migration through inhibition of farnesyl transferase. The Journal of Antibiotics. 66(3). 165–170. 1 indexed citations
6.
Kitagawa, Mitsuhiro, et al.. (2011). A New, Convenient Cell-Based Screening Method for Small-Molecule Glycolytic Inhibitors. Bioscience Biotechnology and Biochemistry. 75(2). 367–369. 6 indexed citations
7.
Kitagawa, Mitsuhiro, Satsuki Ikeda, Etsu Tashiro, Tomoyoshi Soga, & Masaya Imoto. (2010). Metabolomic Identification of the Target of the Filopodia Protrusion Inhibitor Glucopiericidin A. Chemistry & Biology. 17(9). 989–998. 39 indexed citations
8.
Kawatani, Makoto, Hideo Okumura, Kaori Honda, et al.. (2008). The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I. Proceedings of the National Academy of Sciences. 105(33). 11691–11696. 109 indexed citations
10.
Tashiro, Etsu, et al.. (2007). Trierixin, a Novel Inhibitor of ER Stress-induced XBP1 Activation from Streptomyces sp.. The Journal of Antibiotics. 60(9). 547–553. 44 indexed citations
11.
Islam, Md. Sadequl, Mitsuhiro Kitagawa, Masaya Imoto, Takeshi Kitahara, & Hidenori Watanabe. (2006). Synthesis of Gerfelin and Related Analogous Compounds. Bioscience Biotechnology and Biochemistry. 70(10). 2523–2528. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026